Pricing Log in Create free account
Saturday 17 October 2026 Export SYK’s income statement to Excel — free account

Stryker Corporation

SYK Healthcare Medical Devices

Stryker Corporation’s revenue for fiscal 2025 (year ended December 2025) was $25.1 billion, up 11.2% from fiscal 2024. In the quarter to June 2026, revenue grew 9.42%, EPS grew 43.1%, free cash flow grew 14.1% and total debt fell 9.88%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years, revenue growth for five, operating cash flow growth for three.

294.66 1.43 +0.49%
Market cap
$112.5B
P/E
30.3×
Fwd P/E
24.1×
Dividend yield
1.19%
F-score
5/9
Altman Z
4.81
Beneish M
−2.62
Dividend safety
82/100
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

Stryker Corporation (SYK) SEC filings, changes and red flags

Red flags

  • Officer departure

    Stryker Corporation reported the departure of its Chief Executive Officer

    8-K filed · The filing · sec.gov

  • Impairment

    Stryker Corporation recorded a goodwill impairment of $456.0 million in fiscal 2024

    10-K filed · The filing · sec.gov

Filings

Form Period Filed What it reports Flags
8-K Oct 6, 2026 5.02 Departure or appointment of directors or officers; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits Officer departure
10-Q Jun 30, 2026 P1I2: 122 added · 84 removed · 60 modified
P2I1A: no comparison — the Item could not be matched reliably
8-K Jul 30, 2026 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Jun 26, 2026 8.01 Other events; 9.01 Financial statements and exhibits
8-K May 15, 2026 5.02 Departure or appointment of directors or officers; 9.01 Financial statements and exhibits
10-Q Mar 31, 2026
8-K May 6, 2026 5.07 Submission of matters to a vote of security holders
8-K Apr 30, 2026 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K/A Mar 11, 2026 1.05 Material cybersecurity incident; 7.01 Regulation FD disclosure
8-K Mar 23, 2026 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits
8-K Mar 12, 2026 7.01 Regulation FD disclosure
8-K Mar 11, 2026 8.01 Other events
10-K Dec 31, 2025 1: no comparison — the Item could not be matched reliably
1A: no comparison — the Item could not be matched reliably
7: 708 added · 84 removed · 11 modified
8-K Jan 29, 2026 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Dec 4, 2025 5.02 Departure or appointment of directors or officers; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits
10-Q Sep 30, 2025
8-K Oct 30, 2025 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
10-Q Jun 30, 2025
10-K Dec 31, 2024 Impairment

From the company’s filings on sec.gov. Red flags are raised by rules over the filings’ own data and text; they are not investment advice.